[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fWHkhoRRSJw84wz8Wa2LPzRvC5VD9hNL3QRuUzj60fDo":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":6,"topConditions":11,"upcomingReadouts":34,"phaseBuckets":35,"rows":42},"CooperVision, Inc.",[4],154,false,2,0,11198,[12,15,18,21,24,27,29,32],{"name":13,"count":14},"Myopia",98,{"name":16,"count":17},"Astigmatism",33,{"name":19,"count":20},"Presbyopia",16,{"name":22,"count":23},"Ametropia",11,{"name":25,"count":26},"Hyperopia",10,{"name":28,"count":8},"Astigmatism Bilateral",{"name":30,"count":31},"Corneal Staining",1,{"name":33,"count":31},"Contact Lens Solutions",[],[36,37,38,39,40,41],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[]]